However, several targeted therapies have recently been developed for potentially actionable alterations, including BRAF and human epidermal growth factor receptor 2 (HER2) oncogenes, advancing the ...
An unexpected discovery may bring scientists closer to a long-sought goal: finding an ideal immunotherapy target for solid tumors.
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
Perioperative therapy has become a critical component in the management of resectable non–small cell lung cancer (NSCLC), particularly in the era of precision medicine. Although molecular testing is ...
Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene ...
Panel A summarizes the conventional model of how oncogenic RAS guanosine triphosphatases (i.e., Kirsten rat sarcoma viral oncogene homologue [KRAS], neuroblastoma RAS viral oncogene homologue [NRAS], ...
Extrachromosomal DNAs (ecDNAs) are circular DNA structures located in the nuclei of cells outside chromosomes. They were originally discovered in chromosome spreads of cells obtained from embryonal ...
The Medal of Honor is presented to individuals whose research has fundamentally advanced cancer prevention, diagnosis, treatment, and survivorship.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results